Literature DB >> 19924724

Medium to long-term results after reconstruction of bone defects at the knee with tumor endoprostheses.

S Kinkel1, B Lehner, J A Kleinhans, E Jakubowitz, V Ewerbeck, C Heisel.   

Abstract

BACKGROUND AND OBJECTIVES: Limb salvage and reconstruction with tumor endoprostheses is considered as therapeutic standard in the treatment of bone defects at the knee. Few studies report long-term results so far.
METHODS: Seventy-seven patients who had a cementless or cemented MUTARS endoprosthesis implanted were followed-up for a mean period of 46 months (3-128 months). The defects were due to primary tumor lesions in 69 cases or metastases in 8 cases. The distal femur (n = 49) or the proximal tibia (n = 28) was reconstructed predominantly with cementless implants (femur: 69%, tibia: 92%). The resection of the tumor was intraarticular in 46 and extraarticular in 31 patients.
RESULTS: After 10 years probability of limb salvage was 92% with a recurrence rate of 3%. Complications were frequent with a revision rate of 58% and lead to a cumulative probability of survival of the initially implanted prosthesis of 57% after 5 years. Locking mechanism failure (n = 15) and aseptic loosening (n = 13) were the most frequent failure modes.
CONCLUSIONS: Regardless of achieving a low recurrence rate and satisfactory functional results, we found a high complication rate after implantation of a megaprosthesis. This was particularly evident for extraarticular resections and cemented fixation, which should be avoided when possible.

Entities:  

Mesh:

Year:  2010        PMID: 19924724     DOI: 10.1002/jso.21441

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  33 in total

1.  [Megaprostheses of the knee joint].

Authors:  K Anagnostakos; D Kohn
Journal:  Orthopade       Date:  2010-10       Impact factor: 1.087

Review 2.  Megaprosthesis versus Allograft Prosthesis Composite for massive skeletal defects.

Authors:  Deepak Gautam; Rajesh Malhotra
Journal:  J Clin Orthop Trauma       Date:  2017-09-25

3.  How Often Does Spindle Failure Occur in Compressive Osseointegration Endoprostheses for Oncologic Reconstruction?

Authors:  Lauren H Goldman; Lee J Morse; Richard J O'Donnell; Rosanna L Wustrack
Journal:  Clin Orthop Relat Res       Date:  2016-04-22       Impact factor: 4.176

4.  [Alloarthroplasty versus above-knee amputation].

Authors:  K Daniilidis; E Jakubowitz; C Stukenborg-Colsman; T Calließ; H Windhagen; D Yao
Journal:  Orthopade       Date:  2015-06       Impact factor: 1.087

5.  Radiographic assessment of distal femur cemented stems in tumor endoprostheses.

Authors:  R E Turcotte; N A Stavropoulos; J Toreson; M Alsultan
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-04-28

6.  Hydroxyapatite-coated collars reduce radiolucent line progression in cemented distal femoral bone tumor implants.

Authors:  Melanie J Coathup; Anish Sanghrajka; William J Aston; Panagiotis D Gikas; Robin C Pollock; Stephen R Cannon; John A Skinner; Timothy W R Briggs; Gordon W Blunn
Journal:  Clin Orthop Relat Res       Date:  2015-01-30       Impact factor: 4.176

7.  Perioperative infection rate in patients with osteosarcomas treated with resection and prosthetic reconstruction.

Authors:  Xin Li; Vincent M Moretti; Adedayo O Ashana; Richard D Lackman
Journal:  Clin Orthop Relat Res       Date:  2011-05-12       Impact factor: 4.176

8.  Stability of tibial defect reconstruction with fibular graft and unilateral external fixation: a finite element study.

Authors:  Huiqiang Chen; Ying Zhang; Hong Xia; Fei Wang; Zhibo Li; Xuxiang Chen
Journal:  Int J Clin Exp Med       Date:  2014-01-15

9.  Chemotherapy Curtails Bone Formation From Compliant Compression Fixation of Distal Femoral Endoprostheses.

Authors:  Mohammad A Elalfy; Patrick J Boland; John H Healey
Journal:  Clin Orthop Relat Res       Date:  2019-01       Impact factor: 4.176

10.  Survival, complications and functional outcomes of cemented megaprostheses for high-grade osteosarcoma around the knee.

Authors:  Chunlin Zhang; Jianping Hu; Kunpeng Zhu; Tao Cai; Xiaolong Ma
Journal:  Int Orthop       Date:  2018-02-09       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.